PEGASUS study: who would benefit from prolonged DUAL antiplatelet therapy?
Division of Cardiology, San Giovanni Evangelista Hospital, Tivoli (Rome), Italy.
Leonardo
L
De Luca
D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention
D010975:Platelet Aggregation Inhibitors